3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      DNA methylation of intragenic CpG islands depends on their transcriptional activity during differentiation and disease

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Significance

          The human genome contains ∼30,000 CpG islands (CGIs), long stretches (0.5–2 kb) of DNA with unusually elevated levels of CpG dinucleotides. Many occur at genes' promoters, and their DNA nearly always remains unmethylated. Conversely, intragenic CGIs are often, but not always, methylated, and thus inactive as internal promoters. The mechanisms underlying these contrasting patterns of CGI methylation are poorly understood. We show that methylation of intragenic CGIs is associated with transcription running across the island. Whether or not a particular intragenic CGI becomes methylated during development depends on its transcriptional activity relative to that of the gene within which it lies. Our findings explain how intragenic CGIs are epigenetically programmed in normal development and in human diseases, including malignancy.

          Abstract

          The human genome contains ∼30,000 CpG islands (CGIs). While CGIs associated with promoters nearly always remain unmethylated, many of the ∼9,000 CGIs lying within gene bodies become methylated during development and differentiation. Both promoter and intragenic CGIs may also become abnormally methylated as a result of genome rearrangements and in malignancy. The epigenetic mechanisms by which some CGIs become methylated but others, in the same cell, remain unmethylated in these situations are poorly understood. Analyzing specific loci and using a genome-wide analysis, we show that transcription running across CGIs, associated with specific chromatin modifications, is required for DNA methyltransferase 3B (DNMT3B)-mediated DNA methylation of many naturally occurring intragenic CGIs. Importantly, we also show that a subgroup of intragenic CGIs is not sensitive to this process of transcription-mediated methylation and that this correlates with their individual intrinsic capacity to initiate transcription in vivo. We propose a general model of how transcription could act as a primary determinant of the patterns of CGI methylation in normal development and differentiation, and in human disease.

          Related collections

          Most cited references37

          • Record: found
          • Abstract: found
          • Article: not found

          Conserved Role of Intragenic DNA Methylation in Regulating Alternative Promoters

          While the methylation of DNA in 5′ promoters suppresses gene expression, the role of DNA methylation in gene bodies is unclear 1–5 . In mammals, tissue- and cell type-specific methylation is present in a small percentage of 5′ CpG island (CGI) promoters, while a far greater proportion occurs across gene bodies, coinciding with highly conserved sequences 5–10 . Tissue-specific intragenic methylation might reduce, 3 or, paradoxically, enhance transcription elongation efficiency 1,2,4,5 . Capped analysis of gene expression (CAGE) experiments also indicate that transcription commonly initiates within and between genes 11–15 . To investigate the role of intragenic methylation, we generated a map of DNA methylation from human brain encompassing 24.7 million of the 28 million CpG sites. From the dense, high-resolution coverage of CpG islands, the majority of methylated CpG islands were revealed to be in intragenic and intergenic regions, while less than 3% of CpG islands in 5′ promoters were methylated. The CpG islands in all three locations overlapped with RNA markers of transcription initiation, and unmethylated CpG islands also overlapped significantly with trimethylation of H3K4, a histone modification enriched at promoters 16 . The general and CpG-island-specific patterns of methylation are conserved in mouse tissues. An in-depth investigation of the human SHANK3 locus 17,18 and its mouse homologue demonstrated that this tissue-specific DNA methylation regulates intragenic promoter activity in vitro and in vivo. These methylation-regulated, alternative transcripts are expressed in a tissue and cell type-specific manner, and are expressed differentially within a single cell type from distinct brain regions. These results support a major role for intragenic methylation in regulating cell context-specific alternative promoters in gene bodies.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            The evolution of gene expression levels in mammalian organs.

            Changes in gene expression are thought to underlie many of the phenotypic differences between species. However, large-scale analyses of gene expression evolution were until recently prevented by technological limitations. Here we report the sequencing of polyadenylated RNA from six organs across ten species that represent all major mammalian lineages (placentals, marsupials and monotremes) and birds (the evolutionary outgroup), with the goal of understanding the dynamics of mammalian transcriptome evolution. We show that the rate of gene expression evolution varies among organs, lineages and chromosomes, owing to differences in selective pressures: transcriptome change was slow in nervous tissues and rapid in testes, slower in rodents than in apes and monotremes, and rapid for the X chromosome right after its formation. Although gene expression evolution in mammals was strongly shaped by purifying selection, we identify numerous potentially selectively driven expression switches, which occurred at different rates across lineages and tissues and which probably contributed to the specific organ biology of various mammals.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              A chromatin landmark and transcription initiation at most promoters in human cells.

              We describe the results of a genome-wide analysis of human cells that suggests that most protein-coding genes, including most genes thought to be transcriptionally inactive, experience transcription initiation. We found that nucleosomes with H3K4me3 and H3K9,14Ac modifications, together with RNA polymerase II, occupy the promoters of most protein-coding genes in human embryonic stem cells. Only a subset of these genes produce detectable full-length transcripts and are occupied by nucleosomes with H3K36me3 modifications, a hallmark of elongation. The other genes experience transcription initiation but show no evidence of elongation, suggesting that they are predominantly regulated at postinitiation steps. Genes encoding most developmental regulators fall into this group. Our results also identify a class of genes that are excluded from experiencing transcription initiation, at which mechanisms that prevent initiation must predominate. These observations extend to differentiated cells, suggesting that transcription initiation at most genes is a general phenomenon in human cells.
                Bookmark

                Author and article information

                Journal
                Proc Natl Acad Sci U S A
                Proc. Natl. Acad. Sci. U.S.A
                pnas
                pnas
                PNAS
                Proceedings of the National Academy of Sciences of the United States of America
                National Academy of Sciences
                0027-8424
                1091-6490
                5 September 2017
                21 August 2017
                21 August 2017
                : 114
                : 36
                : E7526-E7535
                Affiliations
                [1] aMedical Research Council Molecular Haematology Unit, Weatherall Institute of Molecular Medicine, Oxford University , Oxford OX3 9DS, United Kingdom;
                [2] bDepartment of Genetics, University of Leicester , Leicester LE1 7RH, United Kingdom;
                [3] cDivision of Medical Sciences and Graduate Entry Medicine, School of Medicine, University of Nottingham, Royal Derby Hospital , Derby DE22 3DT, United Kingdom;
                [4] dDepartment of Epigenetics and Molecular Carcinogenesis, Division of Basic Science Research, The University of Texas M. D. Anderson Cancer Center , Smithville, TX 78957;
                [5] e China Novartis Institutes for BioMedical Research , Shanghai 201203, China;
                [6] fMedical Research Council Centre for Regenerative Medicine, The University of Edinburgh, Edinburgh EH16 4UU, United Kingdom
                Author notes
                6To whom correspondence may be addressed. Email: cristina.tufarelli@ 123456nottingham.ac.uk or doug.higgs@ 123456imm.ox.ac.uk .

                Edited by Adrian P. Bird, University of Edinburgh, Edinburgh, United Kingdom, and approved July 28, 2017 (received for review February 23, 2017)

                Author contributions: D.M.J., A.J.H.S., J.R.H., D.R.H., and C.T. designed research; D.M.J., R.J.S.M., M.D.G., R.G., D.G., H.A., T.C., J.T., M.L., B.G., and C.T. performed research; T.C., E.L., M.L., A.J.H.S., J.N.L., J.R.H., D.R.H., and C.T. contributed new reagents/analytic tools; D.M.J., R.J.S.M., J.T., J.R.H., and C.T. analyzed data; D.M.J., D.R.H., and C.T. wrote the paper; and E.L., A.J.H.S., J.N.L., D.R.H., and C.T. provided supervision.

                1Present address: Human Development and Health, Institute of Developmental Sciences, University of Southampton, Southampton SO17 1BJ, United Kingdom.

                2Present address: Dipartimento di Scienze Cliniche e Biologiche, Università degli Studi di Torino, 10043 Orbassano (Torino), Italy.

                3Present address: Seven Bridges Genomics, London NW1 2RA, United Kingdom.

                4Present address: INSERM, UMRS-1126, Institut Universitaire d’Hématologie, Université Paris, 75010 Paris, France.

                5Present address: Centre for Stem Cells and Regenerative Medicine, King’s College London, London WC2R 2LS, United Kingdom.

                Author information
                http://orcid.org/0000-0002-1053-4618
                Article
                PMC5594649 PMC5594649 5594649 201703087
                10.1073/pnas.1703087114
                5594649
                28827334
                24beb4b0-9412-4c46-a335-dabec779cc72

                Freely available online through the PNAS open access option.

                History
                Page count
                Pages: 10
                Funding
                Funded by: RCUK | Medical Research Council (MRC) 501100000265
                Award ID: 4050189188
                Funded by: RCUK | Medical Research Council (MRC) 501100000265
                Award ID: Capacity Building Award
                Funded by: Royal Society 501100000288
                Award ID: DHRF - 8363
                Categories
                PNAS Plus
                Biological Sciences
                Genetics
                PNAS Plus

                CGI transcription,DNA methylation,H3K36me3,intragenic CGIs,CGI methylation

                Comments

                Comment on this article